TWD 57.2
(-5.61%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -3.62 TWD | 9.27% |
2022 | -3.99 TWD | -99.5% |
2021 | -2.00 TWD | 8.68% |
2020 | -2.19 TWD | 22.89% |
2019 | -2.84 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.64 TWD | -14.29% |
2024 Q1 | -0.56 TWD | 31.71% |
2023 Q1 | -0.84 TWD | -16.67% |
2023 Q4 | -0.82 TWD | -38.98% |
2023 Q3 | -0.59 TWD | 57.86% |
2023 Q2 | -1.40 TWD | -66.67% |
2022 Q4 | -0.72 TWD | 0.0% |
2022 FY | - TWD | -99.5% |
2021 FY | - TWD | 8.68% |
2020 FY | - TWD | 22.89% |
2019 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Apex Biotechnology Corp. | 1.16 TWD | 412.069% |
Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 261.607% |
Panion & Bf Biotech Inc. | 0.90 TWD | 502.222% |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 205.848% |
GenMont Biotech Incorporation | 0.38 TWD | 1052.632% |
Abnova (Taiwan) Corporation | 0.72 TWD | 602.778% |
Adimmune Corporation | -1.52 TWD | -138.158% |
Tanvex BioPharma, Inc. | -16.42 TWD | 77.954% |
Polaris Group | -2.12 TWD | -70.755% |
UnicoCell Biomed Co., Ltd. | -1.56 TWD | -132.051% |
PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 58.005% |